hydralazine has been researched along with Weight Reduction in 4 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anker, SD | 1 |
| Negassa, A | 1 |
| Coats, AJ | 1 |
| Afzal, R | 1 |
| Poole-Wilson, PA | 1 |
| Cohn, JN | 1 |
| Yusuf, S | 1 |
| Brink, M | 1 |
| Wellen, J | 1 |
| Delafontaine, P | 1 |
| Lewis, J | 1 |
| Laforest, R | 1 |
| Buettner, T | 1 |
| Song, S | 1 |
| Fujibayashi, Y | 1 |
| Connett, J | 1 |
| Welch, M | 1 |
| Franks, PJ | 1 |
| Hartley, K | 1 |
| Bulpitt, PF | 1 |
| Bulpitt, CJ | 1 |
4 other studies available for hydralazine and Weight Reduction
| Article | Year |
|---|---|
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Data Interpretation, Statistical; D | 2003 |
Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pr | 1996 |
Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.
Topics: Animals; Brachytherapy; Cell Hypoxia; Colorectal Neoplasms; Coordination Complexes; Copper Radioisot | 2001 |
Risk of serious morbidity associated with hydralazine versus methyldopa treatment in hypertensive patients.
Topics: Cardiovascular Diseases; Female; Humans; Hydralazine; Hypertension; Kidney Diseases; Male; Medical R | 1991 |